TG Therapeutics, Inc.
TGTX
$48.74
$0.801.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 441.49M | 461.90M | 447.18M | 447.47M | 60.46M |
| Total Depreciation and Amortization | 123.00K | 83.00K | 59.00K | 47.00K | 41.00K |
| Total Amortization of Deferred Charges | 1.32M | 1.38M | 1.40M | 1.41M | 1.53M |
| Total Other Non-Cash Items | -249.11M | -261.55M | -278.87M | -308.27M | 56.70M |
| Change in Net Operating Assets | -175.95M | -215.76M | -194.54M | -210.73M | -177.85M |
| Cash from Operations | 17.88M | -13.95M | -24.77M | -70.07M | -59.13M |
| Capital Expenditure | -491.00K | -240.00K | -214.00K | -168.00K | -112.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.38M | 17.11M | 14.01M | 45.39M | -10.36M |
| Cash from Investing | 21.89M | 16.87M | 13.80M | 45.23M | -10.47M |
| Total Debt Issued | 747.66M | 747.66M | -- | 0.00 | 244.82M |
| Total Debt Repaid | -255.00M | -255.00M | -- | 0.00 | -107.55M |
| Issuance of Common Stock | 1.91M | 2.25M | 1.51M | 1.02M | 1.22M |
| Repurchase of Common Stock | -178.23M | -185.11M | -91.24M | -97.85M | -21.76M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.60M | -2.60M | -- | -31.00K | -889.00K |
| Cash from Financing | 313.73M | 307.20M | -89.73M | -96.86M | 115.84M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 353.50M | 310.12M | -100.70M | -121.71M | 46.24M |